GFAP versus S100B in serum after traumatic brain injury: Relationship to brain damage and outcome

被引:221
|
作者
Pelinka, LE
Kroepfl, A
Leixnering, M
Buchinger, W
Raabe, A
Redl, H
机构
[1] Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria
[2] Austrian Workers Compensat Board, Res Unit, AUVA, Vienna, Austria
[3] AUVA, Trauma Hosp Linz, Linz, Austria
[4] Waldviertel Clin, Dept Traumatol, Horn, Austria
[5] Goethe Univ Frankfurt, Dept Neurosurg, Neuroctr, D-6000 Frankfurt, Germany
关键词
computerized tomography; GFAP; intracranial pressure; neuromarkers; perfusion pressure; S100B protein;
D O I
10.1089/0897715042441846
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Research indicates that glial fibrillary acidic protein (GFAP), part of the astroglial skeleton, could be a marker of traumatic brain injury (TBI). S100B, an astroglial protein, is an acknowledged marker of TBI. Our goal was to analyze the relationship of GFAP/S100B to brain damage and outcome, and to compare the accuracy of GFAP/S100B for prediction of mortality after TBI. Our prospective study included 92 patients admitted <12 h after TBI (median injury severity score 25, median Glasgow Coma Scale 6). TBI was verfied by computerized tomography. GFAP/S100B were measured immunoluminometrically at admission and daily in the intensive care unit (average 10 days, range 1-21 days). We compared GFAP/S100B in non-survivors versus survivors, accuracy for mortality prediction according to receiver operated characteristic curve analysis, correlation between GFAP and S100B, relationship of GFAP/S100B to computerized tomography, cerebral perfusion pressure (CPP), mean arterial pressure (MAP) and 3-month Glasgow Outcome Score (GOS). GFAP (p < 0.005) and S100B (p < 0.0005) were higher in non-survivors than survivors. Both GFAP and S100B were accurate for mortality prediction (area under curve 0.84 versus 0.78 at <12 h after TBI). GFAP and S100B release correlated better later than 36 h after TBI (r = 0.75) than earlier (r = 0.58). GFAP was lower in focal lesions of <25 mL than in shifts of >0.5 cm (P < 0.0005) and non-evacuated mass lesions of >25 mL (p < 0.005). S100B was lower in focal lesions of <25 mL than in non-evacuated mass lesions (p < 0.0005) and lower in swelling than in shifts of >0.5 cm (p < 0.005). GFAP and S100B were lower in ICP < 25 than ICP greater than or equal to 25 (p < 0.0005), in CPP greater than or equal to 60 than CPP < 60 (p < 0.0005), in MAP > 70 than MAP:5 70 nun Hg, and in GOS 4-5 than GOS 1 (p < 0.0005). Both measurement of GFAP and S100B is a useful non-invasive means of identifying brain damage with some differences based on the pattern of TBI and accompanying multiple trauma and/or shock.
引用
收藏
页码:1553 / 1561
页数:9
相关论文
共 50 条
  • [1] S100B, NSE and GFAP as serum markers of brain damage after traumatic brain injury and multiple trauma: Clinical findings.
    Pelinka, LE
    Hertz, H
    Mauritz, W
    Kroepfl, A
    Buchinger, W
    Raabe, A
    Redl, H
    SHOCK, 2005, 23 : 16 - 17
  • [2] Kinetic modelling of serum S100b after traumatic brain injury
    Ercole, A.
    Thelin, E. P.
    Holst, A.
    Bellander, B. M.
    Nelson, D. W.
    BMC NEUROLOGY, 2016, 16
  • [3] GFAP and S100B in the acute phase of mild traumatic brain injury
    Metting, Z.
    Wilczak, N.
    Rodiger, L. A.
    Schaaf, J. M.
    van der Naalt, J.
    NEUROLOGY, 2012, 78 (18) : 1428 - 1433
  • [4] Kinetic modelling of serum S100b after traumatic brain injury
    A. Ercole
    E. P. Thelin
    A. Holst
    B. M. Bellander
    D. W. Nelson
    BMC Neurology, 16
  • [5] Serum S100B: A marker of brain damage in traumatic brain injury with and without multiple trauma
    Pelinka, LE
    Toegel, E
    Mauritz, W
    Redl, H
    SHOCK, 2003, 19 (03): : 195 - 200
  • [6] THE TEMPORAL PROFILES IN SERUM CONCENTRATIONS OF S100B AFTER TRAUMATIC BRAIN INJURY CORRESPOND TO OUTCOME
    Thelin, Eric
    Bellander, Bo-Michael
    JOURNAL OF NEUROTRAUMA, 2009, 26 (08) : A44 - A44
  • [7] S100B, NSE and GFAP as serum markers of traumatic brain injury: Clinical and experimental studies
    Pelinka, LE
    Bahrami, S
    Redl, H
    Proceedings of the 11th Congress of the European Shock Society, 2005, : 133 - 139
  • [8] Serum Procalcitonin and S100B Are Associated with Mortality after Traumatic Brain Injury
    Linda E. Pelinka
    Helmut Petto
    Albert Kroepfl
    Robert Schmidhammer
    Heinz Redl
    European Journal of Trauma, 2003, 29 (5): : 316 - 323
  • [9] GFAP and S100B are biomarkers of traumatic brain injury An observational cohort study
    Vos, P. E.
    Jacobs, B.
    Andriessen, T. M. J. C.
    Lamers, K. J. B.
    Borm, G. F.
    Beems, T.
    Edwards, M.
    Rosmalen, C. F.
    Vissers, J. L. M.
    NEUROLOGY, 2010, 75 (20) : 1786 - 1793
  • [10] S100B Is an Important Outcome Predictor in Traumatic Brain Injury
    Thelin, Eric Peter
    Johannesson, Louise
    Nelson, David
    Bellander, Bo-Michael
    JOURNAL OF NEUROTRAUMA, 2013, 30 (07) : 519 - 528